Skip to main content
. 2021 Jul 5;7(7):e07475. doi: 10.1016/j.heliyon.2021.e07475

Figure 2.

Figure 2

Perception of facilitators and barriers for clinical trial participation among underrepresented and non-underrepresented fibromyalgia patients.